Aviad Friedman - 03 Jan 2022 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role: Director
Signature: /s/ Aviad Friedman
Issuer symbol: ORMP
Transactions as of: 03 Jan 2022
Transactions value $: $0
Form type: 4
Filing time: 05 Jan 2022, 19:30:20 UTC
Previous filing: 15 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ORMP	Common Stock	Award		+6K			6K	03 Jan 2022	Direct	F1
transaction	ORMP	Common Stock	Gift	$0	-6K	-100%	$0.00^*	0	03 Jan 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ORMP	Stock Option (right to buy	Award	$0	+10K		$0.00	10K	03 Jan 2022	Common Stock	10K	$13.89	Direct	F3
transaction	ORMP	Stock Option (right to buy	Gift	$0	-10K	-100%	$0.00^*	0	03 Jan 2022	Common Stock	10K	$13.89	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
F2	These shares of common stock and stock options were transferred, for no consideration, to a trust with an independent trustee.
F3	The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.